No Data
No Data
Express News | ACADIA Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
Express News | ACADIA Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
Why Acadia Pharmaceuticals (ACAD) Is a Top Momentum Stock for the Long-Term
Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options